Board of Directors
Be A Sponsor
Hot Topic Conference Calls
Oncology Industry News
powered by OBR
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers
Open Payments Data Show Docs Got Most (By Far) From Genentech
Exelixis Provides Update on Genentech’s Pending New Drug Application for Cobimetinib, an Exelixis-Discovered Compound
Become An ACE Member Today!
© Copyright 2013 Association of Cancer Executives.
1025 Thomas Jefferson Street, NW Suite 500 East Washington, DC 20007
powered by MemberClicks